Project STRIDE

Project STRIDE was a randomized, controlled trial of buprenorphine among probationers and pre-trial defendants in the greater Washington, D.C. area who met DSM-IV criteria for opioid dependence and who were under community-based criminal justice supervision. Primary outcomes were HIV treatment (HIV-1 RNA, CD4), substance abuse treatment (time to relapse to opioid use, percent of days using opioids, percent of days abstinent from opioids, addiction severity), adverse side effects, HIV risk behavior (sexual and drug-related risks) and criminal justice (days incarcerated, retention in community supervision, rearrest) outcomes. This project was conducted in collaboration with George Mason University and Howard University.

Funding provided by:
National Institute on Alcohol Abuse and Alcoholism 

Project Period:
August 1, 2010 – August 1, 2014 

Link to Report:
Project Stride at projectreporter.nih.gov